Kyung NAM Pharm053950

Largest holderX20.34%$4.4M

Filed holders65% or more, plus insiders

Price and institutional trades

1Y 2Y

$1.12−64.8%2Y

JanAprJulOctJanAprJulOct

Holders

$4.4M · 2026-07-0320.34%New

$3.2M · 2026-08-2014.48%−5.64pp

$3.1M · 2026-07-0814.28%−13.31pp

$2.9M · direct 7.55% · indirect 5.72% · 2026-07-0813.27%

Direct7.55%
Billions 40.05% → Kyung NAM Pharm 14.28%5.72%

$1.7M · 2025-01-101.90%

Average cost is the mean purchase price from filings since November 2024. Indirect stakes multiply ownership through listed companies.

Indirect-only holders

$505K · indirect2.31%

Billions 16.17% → Kyung NAM Pharm 14.28%2.31%

$454K · indirect

Companies held by Kyung NAM Pharm

Billions$53M · 2026-03-0625.59%Ascendio$7.7M · 2026-08-1444.50%Hanjoo ART$495K · 2025-05-097.54%Satoshi Holdings$480K · 2026-09-181.85%

Filings

Filed	Changed	Before → after	Amount	Avg buy price
2026-08-20	2026-08-14	18.17 → 14.48%	-	-	Filing
2026-07-08	2026-07-02	27.40 → 21.83%	−$0	-	Filing
2026-07-03	2026-07-02	0.00 → 20.34%	+$4.8M	$1.21	Filing
2026-06-26	2026-06-22	30.90 → 27.40%	−$1.9M	-	Filing
2026-04-23	2026-04-16	31.07 → 30.90%	−$86K

Billions 14.52% → Kyung NAM Pharm 14.28%2.07%

$295K · indirect1.35%

Humasis 9.22% → Kyung NAM Pharm 7.55%0.70%
Humasis 9.22% → Billions 40.05% → Kyung NAM Pharm 14.28%0.53%
Billions 0.89% → Kyung NAM Pharm 14.28%0.13%

$229K · indirect1.05%

Humasis 2.17% → Kyung NAM Pharm 7.55%0.16%
Incon 32.29% → Humasis 9.22% → Kyung NAM Pharm 7.55%0.22%
Kbio Labs 40.99% → Incon 23.16% → Humasis 9.22% → Kyung NAM Pharm 7.55%0.07%
Kbio Labs 40.99% → Humasis 4.50% → Kyung NAM Pharm 7.55%0.14%
Humasis 2.17% → Billions 40.05% → Kyung NAM Pharm 14.28%0.12%
Incon 32.29% → Humasis 9.22% → Billions 40.05% → Kyung NAM Pharm 14.28%0.17%
Kbio Labs 40.99% → Humasis 4.50% → Billions 40.05% → Kyung NAM Pharm 14.28%0.11%
Incon 32.29% → Billions 0.89% → Kyung NAM Pharm 14.28%0.04%
Kbio Labs 40.99% → Incon 23.16% → Billions 0.89% → Kyung NAM Pharm 14.28%0.01%

$199K · indirect0.91%

Incon 23.16% → Humasis 9.22% → Kyung NAM Pharm 7.55%0.16%
Humasis 4.50% → Kyung NAM Pharm 7.55%0.34%
Incon 23.16% → Humasis 9.22% → Billions 40.05% → Kyung NAM Pharm 14.28%0.12%
Humasis 4.50% → Billions 40.05% → Kyung NAM Pharm 14.28%0.26%
Incon 23.16% → Billions 0.89% → Kyung NAM Pharm 14.28%0.03%

$158K · indirect0.72%

Humasis 5.44% → Kyung NAM Pharm 7.55%0.41%
Humasis 5.44% → Billions 40.05% → Kyung NAM Pharm 14.28%0.31%

$80K · indirect0.37%

Billions 2.57% → Kyung NAM Pharm 14.28%0.37%

$75K · indirect0.34%

Humasis 2.59% → Kyung NAM Pharm 7.55%0.20%
Humasis 2.59% → Billions 40.05% → Kyung NAM Pharm 14.28%0.15%

$48K · indirect0.22%

MiraeING 31.40% → Humasis 2.17% → Kyung NAM Pharm 7.55%0.05%
MiraeING 31.40% → Incon 32.29% → Humasis 9.22% → Kyung NAM Pharm 7.55%0.07%
MiraeING 31.40% → Kbio Labs 40.99% → Humasis 4.50% → Kyung NAM Pharm 7.55%0.04%
MiraeING 31.40% → Humasis 2.17% → Billions 40.05% → Kyung NAM Pharm 14.28%0.04%
MiraeING 31.40% → Incon 32.29% → Billions 0.89% → Kyung NAM Pharm 14.28%0.01%

$46K · indirect0.21%

Humasis 1.58% → Kyung NAM Pharm 7.55%0.12%
Humasis 1.58% → Billions 40.05% → Kyung NAM Pharm 14.28%0.09%

No direct stake in the filings. It may be under 5% or filed before November 2024, so actual holdings may be larger.

Show 4 unchanged reports

Filed	Changed	Before → after	Amount	Avg buy price
2026-05-21	2026-05-14	18.17 → 18.17%	-	-	Filing
2026-02-24	2026-02-24	18.17 → 18.17%	-	-	Filing
2025-11-21	2025-11-21	18.17 → 18.17%	-	-	Filing
2025-08-22	2025-08-22	18.17 → 18.17%	-	-	Filing

16 in the last 2 years · amount = quantity × price per trade in the last year (closing price where no price is filed), avg buy price = average of buys in that filing · change dates and prices only where the original filing was fetched

· avg $2.23 (partial)

Not a trade −3.69pp

Not a trade −1.95pp

Not a trade −0.00pp